{"paper_id":"e8b78a21-b646-4ee7-8e4e-0c16ae80c231","body_text":"Clinical medicine\nPATHOGENETIC ASPECTS OF STATINS’ APPLICABILITY IN COMBINATION TREATMENT OF PATIENTS WITH UTERINE FIBROIDS AND EXTRAGENITAL PATHOLOGIES\nPublished\n2017-08-29\nAuthors:\nVZ\nZhurakivskyi V.M.\n- Abstract:\n-\nThe article involves materials of thesis research conducted in accordance with the plan of SHEE «Ivano-Frankivsk national medical university» and is a part of academic research work of the department of obstetrics and gynecology named after I.D. Lanovyi “Clinical and medico-social grounding of effective methods for the prediction of pathologic states, diagnosis and treatment of women during pregnancy and other periods of their life” (state registration number 0104U008431).\n- Keywords:\n-\nhyperplastic processes of the uterus lipid metabolism sex hormones statins\n- References:\n-\n- Csatlós E. Uterine leiomyoma / E. Csatlós, J. Jr. Rigó, I. Szabó [et al.] // Orv. Hetil. – 2010. – Vol. 151, № 42. – P. 1734–1741.\n- Ezem B. U. Krukenberg tumour simulating uterine fibroids and pelvic inflammatory disease / B. U. Ezem, C. C. Osuagwu, I. V. Onyiaorah // Niger. J. Clin. Pract. – 2010. – Vol. 13, № 3. – P. 336–337.\n- Kuricheva N. Yu. Differentiated approach to the treatment of endometrial hyperplastic processes in women in the perimenopausal period / N. Yu. Kuricheva // Medytsyna siohodni i zavtra . – 2010. – № 1. – P. 28–32.\n- Lethaby A. Fibroids (uterine myomatosis, leiomyomas) / A.Lethaby, B.Vollenhoven // Clin. Evid. – 2011.– Vol. 41,№ 12. – P. 83–89.\n- Munro M. G. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age / M. G. Munro, H. O. Critchley, M. S. Broder [et al.] // Int. J. Gynaecol. Obstet. – 2011. – Vol. 113, № 1. – P. 3–13.\n- Scheurig-Muenkler C. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life / C. Scheurig-Muenkler, A. Lembcke, V. Froeling [et al.] // Hum. Reprod. – 2011. – Vol. 23, № 7. – P 74–79.\n- Tanfin Z. Endothelin-1: physiological and pathological roles in myometrium / Z. Tanfin, D. Leiber, P. Robin [et al.] // Int. J. Biochem. Cell. Biol. – 2011. – Vol. 43, № 3. – P. 299–302.\n- Tsuiji K. Inhibitory effect of curcumin on uterine leiomyoma cell proliferation / K. Tsuiji, T. Takeda, B. Li [et al.] // Gynecol. Endocrinol. – 2011. – Vol. 27, № 7. – P. 512–517.\n- Wei L. H. Histone Deacetylase 6 Regulates Estrogen Receptor {alpha} in Uterine Leiomyoma / L. H. Wei, P. L. Torng, S. M. Hsiao [et al.] // Reprod Sci. – 2011. – Vol. 3, № 6. – P. 432–437.\n- Ventskivska I. B. Differential treatment of endometrial hyperplastic processes against the background of internal endometriosis / I. B. Ventskivska , L.P. Kuzmiuk // Zdorovie zhenshchiny. – 2010. – № 9. – P. 129–131.\n- Voogt M. J. Uterine Fibroid Embolisation for Symptomatic Uterine Fibroids: A Survey of Clinical Practice in Europe / M. J. Voogt, M. J. Arntz, P. N. Lohle [et al.] // Cardiovasc. Intervent. Radiol. – 2010. – Vol. 29, № 12. – P. 395–399.\n- Publication:\n-\n«World of Medicine and Biology»\nVol. 13 No. 61 (2017), pp. 22-26\nUDC 618.14 – 089 + 618.14 + 618.14-006\nHow to Cite\n1.\nZhurakivskyi V. PATHOGENETIC ASPECTS OF STATINS’ APPLICABILITY IN COMBINATION TREATMENT OF PATIENTS WITH UTERINE FIBROIDS AND EXTRAGENITAL PATHOLOGIES. СМБ [Internet]. 2017 Aug. 29 [cited 2026 Jul. 29];13(61):22-6. Available from: https://womab.com.ua/article/view/2336\nShare","source_license":"CC0","license_restricted":false}